skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
04/21/2020
Application #:
15564917
Filing Dt:
10/06/2017
Publication #:
Pub Dt:
02/21/2019
Inventors:
Nhan Tran, Joseph C. Loftus, Harshil Dhruv
Title:
METHODS OF SENSITIZING A PATIENT WITH GLIOMA TO A THERAPEUTIC AGENT BY ADMINISTERING SMALL HAIRPIN RNA TARGETING PDZ-RHOGEF
Assignment: 1
Reel/Frame:
044405/0862Recorded: 12/15/2017Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/12/2017
Exec Dt:
10/12/2017
Assignee:
445 NORTH FIFTH STREET
SUITE 600
PHOENIX, ARIZONA 85004
Correspondent:
THE NOBLITT GROUP, PLLC
8800 NORTH GAINEY CENTER DRIVE, STE. 279
SCOTTSDALE, AZ 85258
Assignment: 2
Reel/Frame:
044966/0254Recorded: 12/27/2017Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/23/2017
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
044406/0503Recorded: 12/15/2017Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/01/2017
Assignee:
200 FIRST STREET S.W.
ROCHESTER, MINNESOTA 55905
Correspondent:
THE NOBLITT GROUP, PLLC
8800 NORTH GAINEY CENTER DRIVE, STE. 279
SCOTTSDALE, AZ 85258

Search Results as of: 06/21/2024 05:15 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT